ACUITY STRATEGIC PARTNERS LLC

Government Consulting

Filings
81
Clients
6
Total Income
$1,341,000
Years Active
2019–2026

Filings

Year Client Period Income Expenses Doc
2020 NANODX 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$15,000
2020 AMICUS THERAPEUTICS, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
2020 APELLIS PHARMACUETICALS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
2020 TAYSHA GENE THERAPIES 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$10,000
2020 TAYSHA GENE THERAPIES 4th Quarter (Oct 1 - Dec 31)
Registration
2020 APELLIS PHARMACUETICALS 4th Quarter (Oct 1 - Dec 31)
Registration
2020 NANODX 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$15,000
2020 AMICUS THERAPEUTICS, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
2020 NANODX 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$15,000
2020 AMICUS THERAPEUTICS, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
Page 1 of 2  ·  12 filings Next

Clients Represented

ClientFilingsTotal Income
NANODX 26 $575,000
AMICUS THERAPEUTICS, INC. 18 $240,000
APELLIS PHARMACUETICALS 13 $200,000
TAYSHA GENE THERAPIES 13 $110,000
PARATEK PHARMACEUTICALS 8 $216,000
STUDENTS FOR LIFE OF AMERICA 3

Lobbyists

NameDisclosed Prior Position
JEFFREY ANDERS
MICHAEL J EGING
KELSEY HADDOW